Our Board
John W. Ward, MD
Director of the Coalition for Global Hepatitis Elimination at the Task Force for Global Health
John W. Ward, MD is the Director of the Coalition for Global Hepatitis Elimination at the Task Force for Global Health. Prior to the Coalition, Dr. Ward spent his career at the US Centers for Disease Control and Prevention (CDC). Over a 13-year tenure as Director of the CDC Division of Viral Hepatitis, Dr. Ward was responsible for viral hepatitis surveillance, prevention, and research. At the national level, Dr. Ward led development of recommendations for hepatitis vaccination, testing and linkage to care and treatment. Globally, Dr. Ward serves as member of the WHO Strategic Technical Advisory Committee for HIV and Viral Hepatitis and advises WHO regional offices and member countries development and evaluation of viral hepatitis prevention and elimination programs. From 1984-1998, Dr. Ward was a scientist in the CDC HIV/AIDS program conducting epidemiologic studies and directing national HIV/AIDS surveillance. From 1998-2005, Dr. Ward served as Editor of CDC’s Morbidity and Mortality Weekly Report (MMWR) and also as Editor of Silent Victories, a history of public health in the 20th Century published by Oxford University Press. Dr. Ward has authored over 150 publications of scientific work in viral hepatitis and HIV. Dr. Ward is a Professor in the Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta.
Rena Sun
Divisional Vice President APAC at Abbott
Rena Sun, Ph.D., leads Abbott's Infectious Disease business across Asia Pacific (APAC). She is responsible for driving growth, commercial strategy, and business performance across the region. Prior to her current role, Rena held several leadership positions at Abbott, including leading businesses in Canada, Latin America, and Global Commercial for the Point of Care Diagnostics division. Before Abbott, she was an Executive Director at Bristol Myers Squibb, where she led global strategy and performance for solid tumor oncology brands, including Opdivo. Earlier in her career, she led Strategic Insights for Novartis Sandoz US and worked as a management consultant at Boston Consulting Group, serving healthcare clients across Asia and the United States. Rena earned her Ph.D. in Biostatistics from the University of Michigan, with a focus on oncology and transplant clinical trials. She brings over 20 years of healthcare experience across diagnostics, pharmaceuticals, biosimilars, generics, and medical devices, with leadership experience spanning the US, Canada, Latin America, and Asia Pacific.
Rena is passionate about improving patient outcomes through healthcare innovation, expanding access to care, enabling timely diagnosis, and supporting better, more personalized healthcare decisions. Throughout her career, she has been committed to helping patients access the treatments and technologies they need to live healthier lives.
Karan Kampani
APAC Commercial and Disease Area Lead, Infectious Diseases at Roche
Many people look for their mission in life, Karan’s mission chose him 15 years ago when he joined Roche and worked on the launch of a cervical cancer screening test caused by a viral infection (HPV). He has since been deeply involved in Infectious Disease related topics and is passionate about partnering with stakeholders to save one more life.
Karan has more than 17 years of experience in the In Vitro Diagnostics industry. He currently leads the Infectious Diseases area for Asia Pacific, based in Singapore. Karan has previously worked in Malaysia, Switzerland, California, leading teams in various commercial and development roles.